Literature DB >> 17975795

Novel biochemical pathways of endoglin in vascular cell physiology.

Carmelo Bernabeu1, Barbara A Conley, Calvin P H Vary.   

Abstract

The broad role of the transforming growth factor beta (TGFbeta) signaling pathway in vascular development, homeostasis, and repair is well appreciated. Endoglin is emerging as a novel, complex, and poorly understood regulatory component of the TGFbeta receptor complex, whose importance is underscored by its recognition as the site of mutations causing hereditary hemorrhagic telangiectasia (HHT) [McAllister et al., 1994]. Extensive analyses of endoglin function in normal developmental mouse models [Bourdeau et al., 1999; Li et al., 1999; Arthur et al., 2000] and in HHT animal models [Bourdeau et al., 2000; Torsney et al., 2003] exemplify the importance of understanding endoglin's biochemical functions. However, novel mechanisms underlying the regulation of these pathways continue to emerge. These mechanisms include modification of TGFbeta receptor signaling at the ligand and receptor activation level, direct effects of endoglin on cell adhesion and migration, and emerging roles for endoglin in the determination of stem cell fate and tissue patterning. The purpose of this review is to highlight the cellular and molecular studies that underscore the central role of endoglin in vascular development and disease. Copyright (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17975795      PMCID: PMC2199238          DOI: 10.1002/jcb.21594

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  106 in total

1.  Cardiac stem cells in brown adipose tissue express CD133 and induce bone marrow nonhematopoietic cells to differentiate into cardiomyocytes.

Authors:  Yoshihiro Yamada; Shin-ichiro Yokoyama; Xiang-Di Wang; Noboru Fukuda; Nobuyuki Takakura
Journal:  Stem Cells       Date:  2007-02-08       Impact factor: 6.277

2.  Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells.

Authors:  Laurent David; Christine Mallet; Sabine Mazerbourg; Jean-Jacques Feige; Sabine Bailly
Journal:  Blood       Date:  2006-10-26       Impact factor: 22.113

3.  Endoglin differentially modulates antagonistic transforming growth factor-beta1 and BMP-7 signaling.

Authors:  Olaf Scherner; Steffen K Meurer; Lidia Tihaa; Axel M Gressner; Ralf Weiskirchen
Journal:  J Biol Chem       Date:  2007-03-21       Impact factor: 5.157

4.  Soluble endoglin and other circulating antiangiogenic factors in preeclampsia.

Authors:  Richard J Levine; Chun Lam; Cong Qian; Kai F Yu; Sharon E Maynard; Benjamin P Sachs; Baha M Sibai; Franklin H Epstein; Roberto Romero; Ravi Thadhani; S Ananth Karumanchi
Journal:  N Engl J Med       Date:  2006-09-07       Impact factor: 91.245

5.  Endoglin regulates cyclooxygenase-2 expression and activity.

Authors:  Mirjana Jerkic; Juan V Rivas-Elena; Juan F Santibanez; Marta Prieto; Alicia Rodríguez-Barbero; Fernando Perez-Barriocanal; Miguel Pericacho; Miguel Arévalo; Calvin P H Vary; Michelle Letarte; Carmelo Bernabeu; Jose M López-Novoa
Journal:  Circ Res       Date:  2006-07-13       Impact factor: 17.367

6.  The natural history of epistaxis in hereditary hemorrhagic telangiectasia.

Authors:  O S AAssar; C M Friedman; R I White
Journal:  Laryngoscope       Date:  1991-09       Impact factor: 3.325

7.  Endoglin is an accessory protein that interacts with the signaling receptor complex of multiple members of the transforming growth factor-beta superfamily.

Authors:  N P Barbara; J L Wrana; M Letarte
Journal:  J Biol Chem       Date:  1999-01-08       Impact factor: 5.157

8.  Phosphorylation of the human-transforming-growth-factor-beta-binding protein endoglin.

Authors:  P Lastres; J Martín-Perez; C Langa; C Bernabéu
Journal:  Biochem J       Date:  1994-08-01       Impact factor: 3.857

9.  Expression of vascular adhesion molecules on human endothelia in autoimmune thyroid disorders.

Authors:  M Marazuela; F Sánchez-Madrid; A Acevedo; E Larrañaga; M O de Landázuri
Journal:  Clin Exp Immunol       Date:  1995-11       Impact factor: 4.330

10.  Expression of endoglin mRNA and protein in human vascular smooth muscle cells.

Authors:  P J Adam; G J Clesham; P L Weissberg
Journal:  Biochem Biophys Res Commun       Date:  1998-06-09       Impact factor: 3.575

View more
  47 in total

1.  Immunohistochemical analysis of a merkeloma observed in a patient affected by hereditary haemorrhagic telangiectasia.

Authors:  Elisa Rossi; Laura Boeri; Patrizia Morbini; Fabio Pagella; Andrea Colombo; Elina Matti; Carla Olivieri; Vincenzo Villanacci; Antonella Minelli; Elisabetta Buscarini; Cecilia Canzonieri; Cesare Danesino
Journal:  BMJ Case Rep       Date:  2010-02-08

2.  GLP-1 reduces metalloproteinase-14 and soluble endoglin induced by both hyperglycemia and hypoglycemia in type 1 diabetes.

Authors:  Antonio Ceriello; Lucia La Sala; Valeria De Nigris; Gemma Pujadas; Roberto Testa; Annachiara Uccellatore; Stefano Genovese
Journal:  Endocrine       Date:  2015-03-06       Impact factor: 3.633

Review 3.  PECAM-1 isoforms, eNOS and endoglin axis in regulation of angiogenesis.

Authors:  Sunyoung Park; Christine M Sorenson; Nader Sheibani
Journal:  Clin Sci (Lond)       Date:  2015-08       Impact factor: 6.124

4.  CD105 protein depletion enhances human adipose-derived stromal cell osteogenesis through reduction of transforming growth factor β1 (TGF-β1) signaling.

Authors:  Benjamin Levi; Derrick C Wan; Jason P Glotzbach; Jeong Hyun; Michael Januszyk; Daniel Montoro; Michael Sorkin; Aaron W James; Emily R Nelson; Shuli Li; Natalina Quarto; Min Lee; Geoffrey C Gurtner; Michael T Longaker
Journal:  J Biol Chem       Date:  2011-09-23       Impact factor: 5.157

5.  Inhibition of endoglin-GIPC interaction inhibits pancreatic cancer cell growth.

Authors:  Krishnendu Pal; Alexandre A Pletnev; Shamit K Dutta; Enfeng Wang; Ruizhi Zhao; Aradhita Baral; Vinod Kumar Yadav; Suruchi Aggarwal; Soundararajan Krishnaswamy; Khalid M Alkharfy; Shantanu Chowdhury; Mark R Spaller; Debabrata Mukhopadhyay
Journal:  Mol Cancer Ther       Date:  2014-08-14       Impact factor: 6.261

6.  Salivary and serum markers of angiogenesis in periodontitis in relation to smoking.

Authors:  Çiğdem Yılmaz Şaştım; Mervi Gürsoy; Eija Könönen; Akseli Kasurinen; Susanna Norvio; Ulvi Kahraman Gürsoy; Başak Doğan
Journal:  Clin Oral Investig       Date:  2020-07-08       Impact factor: 3.573

7.  Endoglin regulates the activation and quiescence of endothelium by participating in canonical and non-canonical TGF-β signaling pathways.

Authors:  Sunyoung Park; Terri A Dimaio; Wei Liu; Shoujian Wang; Christine M Sorenson; Nader Sheibani
Journal:  J Cell Sci       Date:  2013-02-15       Impact factor: 5.285

8.  Organ-specific lymphangiectasia, arrested lymphatic sprouting, and maturation defects resulting from gene-targeting of the PI3K regulatory isoforms p85alpha, p55alpha, and p50alpha.

Authors:  Carla Mouta-Bellum; Aleksander Kirov; Laura Miceli-Libby; Maria L Mancini; Tatiana V Petrova; Lucy Liaw; Igor Prudovsky; Philip E Thorpe; Naoyuki Miura; Lewis C Cantley; Kari Alitalo; David A Fruman; Calvin P H Vary
Journal:  Dev Dyn       Date:  2009-10       Impact factor: 3.780

9.  CD90 (Thy-1)-positive selection enhances osteogenic capacity of human adipose-derived stromal cells.

Authors:  Michael T Chung; Chunjun Liu; Jeong S Hyun; David D Lo; Daniel T Montoro; Masakazu Hasegawa; Shuli Li; Michael Sorkin; Robert Rennert; Michael Keeney; Fan Yang; Natalina Quarto; Michael T Longaker; Derrick C Wan
Journal:  Tissue Eng Part A       Date:  2013-01-28       Impact factor: 3.845

10.  Endoglin (CD105) up-regulation in pulmonary microvasculature of ventilated preterm infants.

Authors:  Monique E De Paepe; Chintan Patel; Amy Tsai; Sravanthi Gundavarapu; Quanfu Mao
Journal:  Am J Respir Crit Care Med       Date:  2008-04-17       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.